Cargando...
Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update
Macitentan is a medication in the endothelin receptor antagonist class, approved for treatment of pulmonary arterial hypertension in 2013 based on the results of the pivotal SERAPHIN Trial (Study with an Endothelin Receptor Antagonist in Pulmonary arterial Hypertension to Improve cliNical outcome)....
Guardado en:
| Publicado en: | Drug Healthc Patient Saf |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6731963/ https://ncbi.nlm.nih.gov/pubmed/31564989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S173050 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|